Telehealth Market (By Product Type: Hardware, Software, Services; By Delivery Mode: On-premise, Web-based, Cloud-based; By End Use) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2023-2032

The global telehealth market was valued at USD 83.52 billion in 2022 and it is predicted to surpass around USD 719.54 billion by 2032 with a CAGR of 24.03% from 2023 to 2032.

Telehealth Market Size 2023 to 2032

Key Pointers

  • The services segment held the largest share of 47.22% in 2022.
  • Based on delivery mode, the web-based delivery mode held the largest share 45.74% in 2022.
  • The provider segment accounted for the largest share of 53.06% in 2022.
  • North America dominated the market in 2022 with a share of 47.18%.
Report Coverage Details
Market Size in 2022 USD 83.52 billion
Revenue Forecast by 2032 USD 719.54 billion
Growth rate  CAGR of 24.03%
Base Year 2022
Forecast Period 2023 to 2032
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Covered Koninklijke Philips N.V; Siemens Healthineers; Cerner Corp.; GE Healthcare; Medtronic PLC; Teladoc Health Inc; American Well; Doctor on Demand; GlobalMed; MDLive

 

The rising penetration of the internet and innovation in smartphones is enabling to address the gaps in the delivery and availing of telehealth services conveniently. Moreover, the demand for telehealth services witnessed tremendous growth over the past year due to the COVID-19 pandemic and the restrictions imposed in order to curb the infection. COVID-19 hindered the delivery of healthcare services which enabled most healthcare facilities to shift from traditional to virtual care methods. Further, the growing need to monitor health and wellness in order to manage chronic diseases virtually is driving the market growth.

Introduction of web-based and cloud-based platforms which deliver virtual care to users are expected to boost the market growth. For instance, in August 2021, CVS and Teladoc partnered to launch CVS Health’s Aetna Virtual Primary Care. Through this partnership, CVS Health will utilize Teladoc’s physician network and providers to deliver virtual care services to patients remotely through video and telephonic consultations, which will reduce the dependency of the patients on in-person consultations and visits.

Increasing prevalence of cancer globally is expected to be a key contributor to the growth of the market. This increasing prevalence is anticipated to strain the healthcare systems, most of which are witnessing a shortage of healthcare professionals such as doctors and nurses; this is anticipated to drive the adoption of the services globally. According to WHO, healthcare facilities are projected to witness a shortage of 15 million healthcare professionals by 2030, this shortage of healthcare professionals is expected to drive the adoption of AI for the treatment and diagnosis of patients. Telehealth helps to deliver healthcare services digitally and virtually to patients at remote locations. The technology helps to deliver patient-centric care remotely to the patients thereby reducing the need for emergency department visits and reducing the rate of hospitalizations. Despite the advantages, concerns regarding cybersecurity, data privacy, and the high cost of implementation of the services are expected to restrain the growth of the market. Moreover, telehealth focuses on increasing the accessibility of basic healthcare services to patients with enhanced safety and quality.

Telehealth applications have been successful in delivering appropriate care to patients while reducing adverse events and preventing the symptoms to go unnoticed. Innovation in digital healthcare such as smart wearables, the internet of things, advanced healthcare analytics, better internet connectivity, and the rising penetration of smartphones globally are significantly shaping the growth of the industry. 

Market Segmentation

By Product Type

  • Hardware
    • Monitors
    • Medical Peripheral Devices
      • Blood Pressure Meters
      • Blood Glucose Meters
      • Weighing Scales
      • Pulse Oximeters
      • Peak Flow Meters
      • ECG Monitors
      • Others
  • Software
    • Standalone Software
    • Integrated Software
  • Services
    • Remote Patient Monitoring
    • Real-Time Interactions
    • Store and Forward
    • Others

By Delivery Mode

  • On-premise
  • Web-based
  • Cloud-based

By End-use

  • Payers
  • Providers
  • Patients

Frequently Asked Questions

The global telehealth market size was reached at USD 83.52 billion in 2022 and it is projected to hit around USD 719.54 billion by 2032.

The global telehealth market is growing at a compound annual growth rate (CAGR) of 24.03% from 2023 to 2032.

The North America region has accounted for the largest telehealth market share in 2022.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Telehealth Market 

5.1. COVID-19 Landscape: Telehealth Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Telehealth Market, By Product Type

8.1. Telehealth Market, by Product Type, 2023-2032

8.1.1 Hardware

8.1.1.1. Market Revenue and Forecast (2019-2032)

8.1.2. Software

8.1.2.1. Market Revenue and Forecast (2019-2032)

8.1.3. Services

8.1.3.1. Market Revenue and Forecast (2019-2032)

Chapter 9. Global Telehealth Market, By Delivery Mode

9.1. Telehealth Market, by Delivery Mode, 2023-2032

9.1.1. On-premise

9.1.1.1. Market Revenue and Forecast (2019-2032)

9.1.2. Web-based

9.1.2.1. Market Revenue and Forecast (2019-2032)

9.1.3. Cloud-based

9.1.3.1. Market Revenue and Forecast (2019-2032)

Chapter 10. Global Telehealth Market, By End-use 

10.1. Telehealth Market, by End-use, 2023-2032

10.1.1. Payers

10.1.1.1. Market Revenue and Forecast (2019-2032)

10.1.2. Providers

10.1.2.1. Market Revenue and Forecast (2019-2032)

10.1.3. Patients

10.1.3.1. Market Revenue and Forecast (2019-2032)

Chapter 11. Global Telehealth Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product Type (2019-2032)

11.1.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)

11.1.3. Market Revenue and Forecast, by End-use (2019-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product Type (2019-2032)

11.1.4.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)

11.1.4.3. Market Revenue and Forecast, by End-use (2019-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product Type (2019-2032)

11.1.5.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)

11.1.5.3. Market Revenue and Forecast, by End-use (2019-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product Type (2019-2032)

11.2.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)

11.2.3. Market Revenue and Forecast, by End-use (2019-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product Type (2019-2032)

11.2.4.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)

11.2.4.3. Market Revenue and Forecast, by End-use (2019-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product Type (2019-2032)

11.2.5.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)

11.2.5.3. Market Revenue and Forecast, by End-use (2019-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product Type (2019-2032)

11.2.6.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)

11.2.6.3. Market Revenue and Forecast, by End-use (2019-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product Type (2019-2032)

11.2.7.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)

11.2.7.3. Market Revenue and Forecast, by End-use (2019-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product Type (2019-2032)

11.3.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)

11.3.3. Market Revenue and Forecast, by End-use (2019-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product Type (2019-2032)

11.3.4.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)

11.3.4.3. Market Revenue and Forecast, by End-use (2019-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product Type (2019-2032)

11.3.5.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)

11.3.5.3. Market Revenue and Forecast, by End-use (2019-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product Type (2019-2032)

11.3.6.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)

11.3.6.3. Market Revenue and Forecast, by End-use (2019-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product Type (2019-2032)

11.3.7.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)

11.3.7.3. Market Revenue and Forecast, by End-use (2019-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product Type (2019-2032)

11.4.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)

11.4.3. Market Revenue and Forecast, by End-use (2019-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product Type (2019-2032)

11.4.4.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)

11.4.4.3. Market Revenue and Forecast, by End-use (2019-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product Type (2019-2032)

11.4.5.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)

11.4.5.3. Market Revenue and Forecast, by End-use (2019-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product Type (2019-2032)

11.4.6.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)

11.4.6.3. Market Revenue and Forecast, by End-use (2019-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product Type (2019-2032)

11.4.7.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)

11.4.7.3. Market Revenue and Forecast, by End-use (2019-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product Type (2019-2032)

11.5.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)

11.5.3. Market Revenue and Forecast, by End-use (2019-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product Type (2019-2032)

11.5.4.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)

11.5.4.3. Market Revenue and Forecast, by End-use (2019-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product Type (2019-2032)

11.5.5.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)

11.5.5.3. Market Revenue and Forecast, by End-use (2019-2032)

Chapter 12. Company Profiles

12.1. Koninklijke Philips N.V

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Siemens Healthineers

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Cerner Corp.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. GE Healthcare

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Medtronic PLC

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Teladoc Health Inc

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. American Well

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Doctor on Demand

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. GlobalMed

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. MDLive

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers